Abstract |
In the last several years we have reached a certain plateau in the frequency of peritonitis seen in patients. Consequently, a peritonitis rate of one every two patient years may be acceptable. Further reduction of this peritonitis rate will require large efforts on all fronts. One will have to consider what the acceptable cost/risk of peritonitis is in peritoneal dialysis patients. New developments in catheter technology, improved connections, better understanding of patient selection and training programs, improved diagnostic and therapeutic methods in the management of peritonitis, and an understanding of the infectious and immune processes are eagerly awaited.
|
Authors | S I Vas |
Journal | Infectious disease clinics of North America
(Infect Dis Clin North Am)
Vol. 3
Issue 2
Pg. 301-28
(Jun 1989)
ISSN: 0891-5520 [Print] United States |
PMID | 2663984
(Publication Type: Journal Article, Review)
|
Topics |
- Humans
- Peritoneal Dialysis, Continuous Ambulatory
(adverse effects)
- Peritonitis
(diagnosis, drug therapy, etiology)
|